Clinical trials
Active, not recruiting Digestive System Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 19 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 5 |
| Arizona State University | 1 |
| Boston Scientific Corporation | 1 |
| Eli Lilly and Company | 1 |
| Gut-Brain-Axis Therapeutics Inc. | 1 |
| IDRX, Inc., a wholly owned subsidiary of GSK, LLC | 1 |
| Indiana University | 1 |
| Mirum Pharmaceuticals, Inc. | 1 |
| Pfizer | 1 |
| Pichamol Jirapinyo, MD, MPH | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Digestive System Diseases | 19 |
| Gastrointestinal Diseases | 4 |
| Neoplasms | 4 |
| Intestinal Diseases | 3 |
| Obesity | 3 |
| Autism Spectrum Disorder | 2 |
| Carcinoma, Hepatocellular | 2 |
| Colitis, Ulcerative | 2 |
| Colonic Diseases | 2 |
| Colonic Neoplasms | 2 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.